Frustration with Eagles’ struggling run game spikes after recent explanations
Frustration over a struggling Eagles rushing attack won't lessen any after recent explanations.
Latest technology news
Frustration over a struggling Eagles rushing attack won't lessen any after recent explanations.
Pep Guardiola has never coached a European competition game below the Champions League level and on Tuesday leads Manchester City in it for the 100th time. City hosts Bayer Leverkusen looking for a 14...
Is it time for the Colts to panic? Maybe a little…
Colorado could use some help.
I Think Gap (GAP) “Turns Out to be the Winner,” Says Jim Cramer Ramish Cheema Tue, November 25, 2025 at 9:38 PM GMT+8 2 min read In this article: GAP -0.84% We recently published Jim Cramer Discussed ...
Is UnitedHealth Group (UNH) The Best Non-Tech Stock to Buy? Reddit Says Yes Fahad Saleem Tue, November 25, 2025 at 9:38 PM GMT+8 2 min read In this article: UNH -0.29% We recently published Top 10 Non...
What Makes Avient Corp (AVNT) a Lucrative Investment? Soumya Eswaran Tue, November 25, 2025 at 9:38 PM GMT+8 3 min read In this article: AVNT 0.00% Cullen Capital Management, LLC, operating under the ...
Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: CRSP +2.03% CRI...
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: NVAX +2.47% SNY -0.97% Novavax, Inc. (NASDA...
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: SLNO +1.77% Soleno Therapeutic...
Bitcoin Gets Kicked Out of the $2 Trillion Club. Here's Why This Top Bitcoin ETF Is a Buy Anyway. Daniel Foelber, The Motley Fool Tue, November 25, 2025 at 9:39 PM GMT+8 5 min read In this article: BT...
Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 1 min read In this article: APLS +2.65% ...
William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 1 min read In this article: LEGN -3.62% Legen...
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: QURE -0.11% uniQ...
Intellia Therapeutics (NTLA) Downgraded After Safety Concerns and Regulatory Delays Slow Gene-Editing Progress Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: NTLA +...
Bitcoin Miners Face Worst Profit Crisis Ever — Giants are Turning Off Rigs and Chasing Bigger Money in AI Prashant Jha Tue, November 25, 2025 at 9:47 PM GMT+8 3 min read In this article: BTC-USD +1.07...
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 2 min read In this article: ATAI +1.05%...
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst Sheryar Siddiq Tue, November 25, 2025 at 9:39 PM GMT+8 1 min read In this article: AGIO +4.95% Agios...
Is Berkshire Hathaway (BRK.B) The Top Stock to Save Your Portfolio Ahead of Potential AI Bubble Pop? Fahad Saleem Tue, November 25, 2025 at 9:39 PM GMT+8 1 min read In this article: BRK-B +0.75% GOOG ...
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation Neha Gupta Tue, November 25, 2025 at 9:40 PM GMT+8 2 min read In this article: ACHV +0.25% Achieve...